Literature DB >> 19423719

Update in lung cancer 2008.

Sarita Dubey1, Charles A Powell.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19423719      PMCID： PMC2720086          DOI： 10.1164/rccm.200902-0289UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  100 in total

1.  Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma.

Authors:  Akiko M Maeshima; Toshiro Niki; Arafumi Maeshima; Tesshi Yamada; Haruhiko Kondo; Yoshihiro Matsuno
Journal:  Cancer       Date:  2002-12-15       Impact factor: 6.860

Review 2.  Shape of the relapse curve and long-term abstinence among untreated smokers.

Authors:  John R Hughes; Josue Keely; Shelly Naud
Journal:  Addiction       Date:  2004-01       Impact factor: 6.526

Review 3.  Genetic susceptibility to lung cancer: the role of DNA damage and repair.

Authors:  Margaret R Spitz; Qingyi Wei; Qiong Dong; Christopher I Amos; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-08       Impact factor: 4.254

Review 4.  The new World Health Organization classification of lung tumours.

Authors:  E Brambilla; W D Travis; T V Colby; B Corrin; Y Shimosato
Journal:  Eur Respir J       Date:  2001-12       Impact factor: 16.671

5.  Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.

Authors:  Kazumasa Noda; Yutaka Nishiwaki; Masaaki Kawahara; Shunichi Negoro; Takahiko Sugiura; Akira Yokoyama; Masahiro Fukuoka; Kiyoshi Mori; Koshiro Watanabe; Tomohide Tamura; Seiichiro Yamamoto; Nagahiro Saijo
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

6.  Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung.

Authors:  K Suzuki; T Yokose; J Yoshida; M Nishimura; K Takahashi; K Nagai; Y Nishiwaki
Journal:  Ann Thorac Surg       Date:  2000-03       Impact factor: 4.330

7.  Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung.

Authors:  Ottavio Rena; Esther Papalia; Enrico Ruffini; Caterina Casadio; Pier Luigi Filosso; Alberto Oliaro; Giuliano Maggi
Journal:  Eur J Cardiothorac Surg       Date:  2003-03       Impact factor: 4.191

8.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

Authors:  Rodrigo Arriagada; Bengt Bergman; Ariane Dunant; Thierry Le Chevalier; Jean-Pierre Pignon; Johan Vansteenkiste
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

9.  Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Authors:  David G Beer; Sharon L R Kardia; Chiang-Ching Huang; Thomas J Giordano; Albert M Levin; David E Misek; Lin Lin; Guoan Chen; Tarek G Gharib; Dafydd G Thomas; Michelle L Lizyness; Rork Kuick; Satoru Hayasaka; Jeremy M G Taylor; Mark D Iannettoni; Mark B Orringer; Samir Hanash
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

10.  Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization.

Authors:  Hiroshi Terasaki; Toshiro Niki; Yoshihiro Matsuno; Tesshi Yamada; Arafumi Maeshima; Hisao Asamura; Naofumi Hayabuchi; Setsuo Hirohashi
Journal:  Am J Surg Pathol       Date:  2003-07       Impact factor: 6.394
View more
  21 in total

1.  Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma.

Authors:  Heather E Metz; Julia Kargl; Stephanie E Busch; Kyoung-Hee Kim; Brenda F Kurland; Shira R Abberbock; Julie Randolph-Habecker; Sue E Knoblaugh; Jay K Kolls; Morris F White; A McGarry Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-20       Impact factor: 11.205

2.  Clinical characteristics and outcomes of patients with small cell lung cancer detected by CT screening.

Authors:  Toshirou Fukushima; Kazunari Tateishi; Hiroshi Yamamoto; Masayuki Hanaoka; Keishi Kubo; Tomonobu Koizumi
Journal:  Med Oncol       Date:  2013-06-06       Impact factor: 3.064

3.  Update in lung cancer and oncological disorders 2010.

Authors:  Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-08-01       Impact factor: 21.405

4.  Respiratory disorders: Ironing out smoking-related airway disease.

Authors:  Thomas J Mariani
Journal:  Nature       Date:  2016-03-09       Impact factor: 49.962

5.  Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer.

Authors:  Yen-Tsung Huang; Xihong Lin; Yan Liu; Lucian R Chirieac; Ray McGovern; John Wain; Rebecca Heist; Vidar Skaug; Shanbeh Zienolddiny; Aage Haugen; Li Su; Edward A Fox; Kwok-Kin Wong; David C Christiani
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

6.  CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.

Authors:  Pallavi Lagisetty; Prachi Vilekar; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Bioorg Med Chem       Date:  2010-06-22       Impact factor: 3.641

7.  Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo.

Authors:  Yi-Fan Hsu; Daniel Ajona; Leticia Corrales; Jose M Lopez-Picazo; Alfonso Gurpide; Luis M Montuenga; Ruben Pio
Journal:  Mol Cancer       Date:  2010-06-07       Impact factor: 27.401

Review 8.  The role of vimentin intermediate filaments in the progression of lung cancer.

Authors:  Martha E Kidd; Dale K Shumaker; Karen M Ridge
Journal:  Am J Respir Cell Mol Biol       Date:  2014-01       Impact factor: 6.914

9.  Gene expression profiles on predicting protein interaction network and exploring of new treatments for lung cancer.

Authors:  Zehui Yang; Rui Zheng; Yuan Gao; Qiang Zhang
Journal:  Mol Biol Rep       Date:  2014-09-10       Impact factor: 2.316

10.  N-methylpurine DNA glycosylase and OGG1 DNA repair activities: opposite associations with lung cancer risk.

Authors:  Yael Leitner-Dagan; Ziv Sevilya; Mila Pinchev; Ran Kramer; Dalia Elinger; Laila C Roisman; Hedy S Rennert; Edna Schechtman; Laurence Freedman; Gad Rennert; Zvi Livneh; Tamar Paz-Elizur
Journal:  J Natl Cancer Inst       Date:  2012-10-27       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.